Proton ( 1 H NMR) and carbon ( 13 C NMR) nuclear magnetic resonance spectra were recorded on a Bruker Avance 400 spectrometer at 400 MHz and 100 MHz, or a Bruker Avance 500 spectrometer at 500 MHz and 125 MHz if specified. The chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The solvent peak was used as a reference value, for 1 H NMR: CDCl 3 = 7.27 ppm, C 6 D 6 = 7.16 ppm, (CD 3 ) 2 SO = 2.50 ppm, CD 3 CN = 1.94; for 13 C NMR: CDCl 3 = 77.0 ppm, C 6 D 6 = 128.0 ppm (CD 3 ) 2 SO = 39.5 ppm. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet of triplets; br = broad). High resolution and low resolution mass spectra were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate by dissolving the compound in CH 2 Cl 2 and then evaporating the CH 2 Cl 2 . Melting points were obtained using a Mel-Temp capillary melting point apparatus and are uncorrected. Acetonitrile and CH 2 Cl 2 were distilled under N 2 from CaH 2 . p-Dioxane and dimethylformamide were purchased from Sigma Aldrich and stored over 4 Ǻ molecular sieves prior to use. Phosgene (20% solution in toluene), trimethylacetonitrile, neopentyl alcohol, 4-methoxybenzonitrile, 4-(trifluoromethyl)benzonitrile, benzyl chloroformate, 4-nitrobenzyl chloroformate, bis(pinacolato)diboron, Pd(dppf)Cl 2 . CH 2 Cl 2 , potassium acetate, 2,2,5,7,8-pentamethyl-6-chromanol, ammonium fluoride, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDCI), 4-(dimethylamino)pyridine (DMAP), (4-carboxybutyl)triphenylphosphonium bromide, urea hydrogen peroxide, DBU, and dithiothreitol were purchased from Sigma Aldrich, checked for purity, and used without further purification. Schwartz's reagent was prepared according to a known literature procedure.
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl ((neopentyloxy)(4-(trifluoromethyl)phenyl)methyl)carbamate (11)
Prepared according to the general carbamate synthesis protocol with 4-(trifluoromethyl)benzonitrile (96 mg, 0.56 mmol), CH 2 Cl 2 (4.0 mL), Cp 2 Zr(H)Cl (176 mg, 0.684 mmol), chloroformate 2 (195 mg, 0.658 mmol), and neopentyl alcohol (2.0 M in CH 2 Cl 2 , 2.6 mL, 5.2 mmol). The reaction was quenched with saturated NaHCO 3 (5 mL). The mixture was extracted with CH 2 Cl 2 (3 x 10 mL), and the combined organic extracts were washed with brine (30 mL), dried (Na 2 SO 4 ) and concentrated. The residue was purified by flash chromatography (CH 2 
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl ((4-methoxyphenyl)(neopentyloxy)methyl)carbamate (12)
Prepared according to the general carbamate synthesis protocol with 4-methoxybenzonitrile (74 mg, 0.56 mmol), CH 2 Cl 2 (4.0 mL), Cp 2 Zr(H)Cl (173 mg, 0.672 mmol), chloroformate 2 (201 mg, 0.679 mmol), and neopentyl alcohol (2.0 M in CH 2 Cl 2 , 2.5 mL, 5.0 mmol). The reaction was quenched with saturated NaHCO 3 (5 mL). The mixture was extracted with CH 2 Cl 2 (3 x 10 mL), and the combined organic extracts were washed with brine (30 mL), dried (Na 2 SO 4 ) and concentrated. The residue was purified by flash chromatography (CH 2 8 .77 mmol) in degassed DMF (13.0 mL) was stirred at 80 °C in a sealed vial for 6 h. The reaction was allowed to cool to rt and was then diluted with a THF/EtOAc mixture (1:4, 50 mL). The reaction mixture was washed successively with a water/brine mixture (1:1, 50 mL) and brine (2 x 50 mL) before being passed through a silica plug consisting of (from top to bottom): celite, activated charcoal, silica, Na 2 
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4-(acetoxy)benzyl chloroformate (S11)
The title compound was prepared according to the general chloroformate synthesis protocol with the following amounts of reagents: 4-acetoxybenzyl alcohol (433 mg, 2.61 mmol), 20% phosgene solution (2.60 mL, 5.26 mmol) and p-dioxane (1.30 mL). After removal of volatiles, crude product was dried over anhydrous Na 2 SO 4 prior to use. 2,2-dimethyl-1-(neopentyloxy) propyl)carbamoyl)oxy)methyl)phenyl acetate (19) Prepared according to the general carbamate synthesis protocol with trimethylacetonitrile (49 mg, 0.59 mmol), CH 2 Cl 2 (4.5 mL), Cp 2 Zr(H)Cl (186 mg, 0.723 mmol), S11 (161 mg, 0.704 mmol), and neopentyl alcohol (2.0 M in CH 2 Cl 2 , 2.65 mL, 5.3 mmol). The reaction was quenched with saturated NaHCO 3 (5 mL). The mixture was extracted with CH 2 Cl 2 (3 x 10 mL), and the combined organic extracts were washed with brine (30 mL), dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (0% to 3% EtOAc in CH 2 Cl 2 ) to afford the desired product (123 mg, 57%) as an oil. 
4-((((

4-azidobenzyl chloroformate (S12)
Prepared according to the general chloroformate synthesis protocol with 4-azidobenzyl alcohol (147 mg, 0.988 mmol), 20% phosgene solution (1.00 mL, 2.02 mmol) and p-dioxane (0.50 mL). After removal of volatiles, the crude product was dried over anhydrous Na 2 
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl (2,2-dimethyl-1-(3-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)propoxy)propyl)carbamate (22)
Prepared according to the general carbamate synthesis protocol with trimethylacetonitrile (62 mg, 0.75 mmol), CH 2 Cl 2 (6.0 mL), Cp 2 Zr(H)Cl (233 mg, 0.903 mmol), chloroformate 2 (254 mg, 0.858 mmol), and alcohol 23 (602 mg, 2.57 mmol). The reaction was quenched with saturated NaHCO 3 (5 mL). The mixture was extracted with CH 2 Cl 2 (3 x 15 mL), and the combined organic extracts were washed with brine (45 mL), dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (2% to 4% ether in CH 2 Cl 2 ) to afford the desired product (132 mg, 30%) as a foamy solid (m.p. = 74 -78 °C 
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl (5-((tert-butyldimethylsilyl)oxy)-2,2-dimethyl-1-((2,2,5,6,8-pentamethylchroman-7-yl)oxy)pentyl)carbamate (26)
Prepared according to the general carbamate synthesis protocol with nitrile 25 (290 mg, 1.20 mmol), CH 2 Cl 2 (8.5 mL), Cp 2 Zr(H)Cl (388 mg, 1.51 mmol), chloroformate 2 (629 mg, 2.12 mmol), and 2,2,5,7,8-pentamethyl-6-chromanol (1.22 g, 5.53 mmol). The reaction was quenched with saturated NaHCO 3 (15 mL). The mixture was extracted with CH 2 Cl 2 (3 x 20 mL), and the combined organic extracts were washed with brine (60 mL), dried (Na 2 SO 4 ) and concentrated. Excess 2,2,5,7,8-pentamethyl-6-chromanol was removed via crystallization from hexanes, after which the filtrate was concentrated. The residue was purified by column chromatography (0% to 4% ether in CH 2 Cl 2 ) to afford the desired product (506 mg, 58%) as a foam. The product appeared as ~3:1 mixture of rotamers by 1 H NMR. hydroxy-2,2-dimethyl-1-((2,2,5,6,8-pentamethylchroman-7 yl)oxy)pentyl)carbamate (S13) A solution of 26 (55 mg, 0.076 mmol) in MeOH (0.5 mL) was treated with NH 4 F (50 mg, 1.4 mmol), and the reaction mixture stirred in a sealed vial for 3 d. The mixture was concentrated in vacuo, after which the residue was diluted in CH 2 Cl 2 (5 mL) and H 2 O (5 mL). The mixture was extracted with CH 2 Cl 2 (3 x 5 mL), and the pooled organic layers were washed successively with H 2 O and brine before being dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (14% ether in CH 2 
Carbamate phosphonium ion 28
A mixture containing S13 (70 mg, 0.11 mmol), 27 (55 mg, 0.12 mmol), EDCI (38 mg, 0.20 mmol), 4-(dimethylamino)pyridine (1.6 mg, 0.013 mmol), and CH 2 Cl 2 (4.0 mL) stirred at rt in a sealed vial for 4.5 h. The reaction was quenched with ice water and extracted with CH 2 Cl 2 (3 x 10 mL). The pooled extracts were dried (Na 2 SO 4 ) and concentrated, and the residue was purified by column chromatography (2% to 5% MeOH in CH 2 Cl 2 ) to afford the desired product , 1.93 mmol) . The reaction was quenched with saturated NaHCO 3 (15 mL). The mixture was extracted with CH 2 Cl 2 (3 x 20 mL), and the combined organic extracts were washed with brine (60 mL), dried (Na 2 SO 4 ) and concentrated. Excess 2,2,5,7,8-pentamethyl-6-chromanol was removed via crystallization from hexanes, after which the filtrate was concentrated. The residue was purified by column chromatography (1% to 2% ether in CH 2 Cl 2 ) to afford the desired product (104 mg, 41%) as a foam. By NMR, the product appeared as ~3:1 mixture of rotamers. 
Benzyl
(5-hydroxy-2,2-dimethyl-1-((2,2,5,7,8-pentamethylchroman-6-yl)oxy)pentyl)carbamate (S15) A solution of S14 (80 mg, 0.13 mmol) in MeOH (0.80 mL) was treated with NH 4 F (50 mg, 1.4 mmol), and the reaction mixture stirred in a sealed vial for 3 days. The reaction was concentrated in vacuo, after which the residue was diluted in CH 2 Cl 2 (5 mL) and H 2 O (5 mL). The mixture was extracted with CH 2 Cl 2 (3 x 5 mL), and the pooled organic layers were washed successively with H 2 O and brine before being dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (15% ether in CH 2 Cl 2 ) to afford the desired product (61 mg, 94%) as a foam. By NMR, the product appeared as ~3:1 mixture of rotamers. 
Carbamate 29
A mixture containing S15 (49 mg, 0.10 mmol), 27 (56 mg, 0.13 mmol), EDCI (36 mg, 0.19 mmol), 4-(dimethylamino)pyridine (3 mg, 0.03 mmol), and CH 2 Cl 2 (4.0 mL) stirred at room temperature in a sealed vial for 1.5 hours. The reaction was quenched with ice water and extracted with CH 2 Cl 2 (3 x 10 mL). The pooled extracts were dried (Na 2 SO 4 ) and concentrated, and the residue was purified by column chromatography (3.5% to 5% MeOH in CH 2 Cl 2 ) to afford the desired product (82 mg, 88%) as a foam. By NMR, the product appeared as ~3:1 mixture of rotamers. 
